ConductScience.org, home

Trial · NCT02102100

The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users

NCT02102100, Not applicable, Completed, Yale University; results first posted 2019-02-20

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users. Trials, record NCT02102100. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02102100

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT number
NCT02102100
Status
Completed
Phases
Not applicable
Enrollment
57 participants, actual
Lead sponsor
Yale University
Conditions
Nicotine Dependence
Interventions
nicotine, menthol
First posted
2014-04-02
Last updated
2020-03-19
Results first posted
2019-02-20

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDrug Effects Questionnaire (DEQ)- 'Good Drug Effects'up to 55 minutes post-infusion
The Drug Effects Questionnaire (DEQ) is used in studies of acute subjective response (SR) to a variety of substances. The DEQ consists of 11 questions: cooling effect, dislike the sensation, any sensations, feel a drug effect, high, feel stimulated, feel a head rush, like drug effect, dislike any effects, craving a cigarette, and like more of the drug. To calculate the DEQ- 'Good Drug Effects', peak values from post-infusion time points were calculated for the change in the intensity of positive subjective effects as measured with 2 DEQ questions - DEQ question #6 'like drug effect' and DEQ question #11 'would like more of the drug'. Each question was measured on a scale with a minimum score of 0 and a maximum score of 100.The peak values for "like" and " I want more" were averaged to obtain a summary score to represent the feel 'Good Drug Effects' composite factor. DEQ measures were skewed and square root transformations were used. Higher scores indicate more positive effects.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYDrug Effects Questionnaire (DEQ)- 'Good Drug Effects'up to 55 minutes post-infusionscores on a scaleLEAST_SQUARES_MEAN

Results by group14

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Menthol-Preferring SmokersAcross Conditions (main effect)5.1979Standard Error 0.3803scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Non-Menthol Preferring SmokersAcross Conditions (main effect)6.8384Standard Error 0.4292scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Menthol-Preferring SmokersHigh Menthol w High Nicotine5.6235Standard Error 0.4731scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Non-Menthol Preferring SmokersHigh Menthol w High Nicotine7.6285Standard Error 0.5287scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Menthol-Preferring SmokersHigh Menthol w Low Nicotine5.226Standard Error 0.4766scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Non-Menthol Preferring SmokersHigh Menthol w Low Nicotine7.4351Standard Error 0.5302scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Menthol-Preferring SmokersHigh Menthol w Saline5.0699Standard Error 0.4768scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Non-Menthol Preferring SmokersHigh Menthol w Saline7.6285Standard Error 0.5287scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Menthol-Preferring SmokersLow Menthol w High Nicotine5.8971Standard Error 0.4736scores on a scale
Drug Effects Questionnaire (DEQ)- 'Good Drug Effects'Non-Menthol Preferring SmokersLow Menthol w High Nicotine7.5808Standard Error 0.5346scores on a scale

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDMenthol-Preferring Smokers32
Overall StudySTARTEDNon-Methol Preferring Smokers25
Overall StudyCOMPLETEDMenthol-Preferring Smokers23
Overall StudyCOMPLETEDNon-Methol Preferring Smokers18
Overall StudyNOT COMPLETEDMenthol-Preferring Smokers9
Overall StudyNOT COMPLETEDNon-Methol Preferring Smokers7

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityMenthol-Preferring Smokers032
Total, all-cause mortalityNon-Menthol Preferring Smokers025
Total, other adverse eventsMenthol-Preferring Smokers032
Total, other adverse eventsNon-Menthol Preferring Smokers025
Total, serious adverse eventsMenthol-Preferring Smokers032
Total, serious adverse eventsNon-Menthol Preferring Smokers025

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
P50DA036151Yale Tobacco Center of Regulatory ScienceKRISHNAN-SARIN, SUCHITRA; O'MALLEY, STEPHANIE SYALE UNIVERSITYNATIONAL INSTITUTE ON DRUG ABUSE2013 to 2017

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Menthol-Preferring Smokers vs Non-Menthol Preferring Smokers: deaths from any causeTrial comparisons
Menthol-Preferring Smokers vs Non-Menthol Preferring Smokers: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02102100

GET https://conductscience.org/api/trials/v1/NCT02102100/registered